GSA Capital Partners’s Protara Therapeutics TARA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$282K	Buy	93,113 +38,256	+70%	+$116K	0.02%	1296
2025 Q1	$234K	Buy	54,857 +19,310	+54%	+$82.4K	0.02%	1312
2024 Q4	$188K	Buy	+35,547	New	+$188K	0.01%	1431